cysteamine has been researched along with Pituitary Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Besouw, MT; Levtchenko, EN; Noordam, K; Willemsen, MA | 1 |
| Dannies, PS; Scammell, JG | 1 |
| Millard, WJ; Romano, TM | 1 |
| Burrage, TG; Dannies, PS; Eisenfeld, AJ; Scammell, JG | 1 |
4 other study(ies) available for cysteamine and Pituitary Neoplasms
| Article | Year |
|---|---|
Growth hormone producing prolactinoma in juvenile cystinosis: a simple coincidence?
Topics: Administration, Oral; Administration, Topical; Body Height; Cabergoline; Child; Cysteamine; Cystinosis; Dopamine Agonists; Ergolines; Headache; Human Growth Hormone; Humans; Male; Ophthalmic Solutions; Pituitary Neoplasms; Prolactinoma; Radiation-Protective Agents; Treatment Outcome | 2008 |
Depletion of pituitary prolactin by cysteamine is due to loss of immunological activity.
Topics: Animals; Cells, Cultured; Cysteamine; Female; Immune Sera; Immunoassay; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred F344 | 1984 |
Comparison of efficacy of cysteamine in depleting prolactin immunoreactivity in different hyperprolactinemic animal models.
Topics: Analysis of Variance; Animals; Cysteamine; Disease Models, Animal; Female; Hyperprolactinemia; Paraneoplastic Endocrine Syndromes; Pituitary Gland; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred ACI; Rats, Inbred BUF; Rats, Inbred WF | 1991 |
Cysteamine causes reduction of prolactin monomers followed by aggregation in the rat pituitary gland.
Topics: Animals; Cysteamine; Cytoplasmic Granules; Dithiothreitol; Female; Growth Hormone; Pituitary Gland; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred F344; Sulfhydryl Reagents | 1985 |